Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Acq. announced
Quarterly results
Consulting agrmnt
CC transcript
LABORATORY CORP OF AMERICA HOLDINGS (LH) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/25/2018 BW LabCorp Announces Strong 2018 First Quarter Results and Updates 2018 Guidance
02/06/2018 BW LabCorp Announces Record 2017 Fourth Quarter and Full Year Results and Provides 2018 Guidance
10/25/2017 BW LabCorp Announces Record Third Quarter Results and Increases 2017 Guidance
07/31/2017 BW LabCorp to Acquire Chiltern for Approximately $1.2 Billion in Cash, Advancing Its Leadership in Drug Development
07/26/2017 BW LabCorp Announces Record Results in the Second Quarter of 2017 and Increases 2017 Guidance
05/04/2017 BW LabCorp to Webcast Its Annual Meeting of Shareholders
04/25/2017 BW Laboratory Corporation of America® Holdings Announces 2017 First Quarter Results and Updates 2017 Guidance
02/16/2017 BW Laboratory Corporation of America® Holdings Announces Record 2016 Fourth Quarter and Full Year Results and Provides 2017 Guidance
08/15/2011 BW LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc.
07/21/2011 BW Laboratory Corporation of America® Holdings Announces Second Quarter 2011 Results
07/01/2011 BW Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021
06/01/2011 BW LabCorp Enters into Definitive Agreement to Acquire Clearstone Central Laboratories
05/18/2011 BW LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc.
04/21/2011 BW Laboratory Corporation of America® Holdings Announces First Quarter 2011 Results
04/19/2011 BW LabCorp Commences Cash Tender Offer for All Outstanding Shares of Orchid Cellmark Inc.
04/06/2011 BW LabCorp Announces Definitive Agreement to Acquire Orchid Cellmark Inc.
04/04/2011 BW Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021
03/14/2011 BW LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest
03/09/2011 BW LabCorp is Scheduled to Present at the Barclays Capital 2011 Global Healthcare Conference
02/23/2011 BW LabCorp is Scheduled to Speak at RBC Capital Markets' 2011 Healthcare Conference
02/10/2011 BW Laboratory Corporation of America® Holdings Announces 2010 Fourth Quarter and Full Year Results
12/07/2010 BW N. Anthony Coles, M.D. Named to LabCorp® Board of Directors
12/01/2010 BW LabCorp Successfully Completes Acquisition of Genzyme Genetics
11/22/2010 BW LabCorp is Scheduled to Present at the 22nd Annual Piper Jaffray Health Care Conference
11/18/2010 BW LabCorp's Acquisition of Genzyme Genetics Clears Antitrust Review
11/16/2010 BW LabCorp Announces Proposed Sale of up to $925 Million of Senior Notes
11/05/2010 BW LabCorp is Scheduled to Present at the Credit Suisse 2010 Annual Healthcare Conference
10/21/2010 BW Laboratory Corporation of America® Holdings Announces 2010 Third Quarter Results
09/13/2010 BW LabCorp Enters into Definitive Agreement to Acquire Genzyme Genetics
09/08/2010 BW LabCorp is Scheduled to Present at the Bank of America Merrill Lynch Investment Conference
08/23/2010 BW LabCorp Enhances HCV Testing Services with the Launch of IL-28B Test
08/12/2010 BW LabCorp Establishes Global Clinical Trials Collaboration with Clearstone Central Labs
08/09/2010 BW LabCorp Announces $250 Million Stock Repurchase Program
07/22/2010 BW Laboratory Corporation of America® Holdings Announces 2010 Second Quarter Results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy